131 results
8-K
EX-10.2
APVO
Aptevo Therapeutics Inc
15 Apr 24
Aptevo Therapeutics Announces Pricing of $4.6 Million Public Offering
4:17pm
audit adjustments.
(i)Material Changes; Undisclosed Events, Liabilities or Developments. Since the date of the latest audited financial statements
8-K
EX-10.2
8wbbdb1 7f
4 Aug 23
Entry into a Material Definitive Agreement
6:51pm